Inovio Pharmaceuticals(DE:GBM)
€1.26-0.02 (-1.80%)
DE:GBM
Inovio Pharmaceuticals earnings date
€1.26
At close:-0.02 (-1.80%)
Inovio Pharmaceuticals (GBM) Q2 2021 Earnings Report
6 Followers
DE:GBM Q2 2021 EPS Results
- Actual EPS
- -EUR 4.26
- Consensus EPS
- -EUR 2.72
- Beat/Miss
- Missed by -EUR 1.54
- One Year Ago EPS
- -EUR 9.06
DE:GBM Q2 2021 Revenue Results
- Actual Revenue
- EUR 248.20K
- Expected Revenue
- EUR 992.53K
- Beat/Miss
- Missed by -EUR 744.33K
- YoY Revenue Growth
- +2.11%
Earnings Announcement Details
- Quarter
- Q2 2021
- Date
- 08/09/2021
- Time
- After Close
- Conference Call
- Monday, August 9, 2021
DE:GBM Upcoming Earnings
Inovio Pharmaceuticals's next earnings date is estimated for March 2, 2027, based on past reporting schedules.
Q2 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:GBM Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 02, 2027 | 2026 (Q4) | -0.12- | 0.05 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.19-0.45 | -0.79 | 42.53% (+0.34) | |
| Aug 12, 2026 | 2026 (Q2) | -0.20-0.06 | -0.55 | 88.52% (+0.49) | |
| May 13, 2026 | 2026 (Q1) | -0.32-0.25 | -0.46 | 45.10% (+0.21) | |
| Mar 12, 2026 | 2025 (Q4) | -0.330.05 | -0.59 | 109.23% (+0.65) | |
| Nov 10, 2025 | 2025 (Q3) | -0.38-0.79 | -0.81 | 2.25% (+0.02) | |
| Aug 12, 2025 | 2025 (Q2) | -0.55-0.55 | -1.08 | 48.74% (+0.53) | |
| May 13, 2025 | 2025 (Q1) | -0.63-0.46 | -1.19 | 61.07% (+0.73) | |
| Mar 18, 2025 | 2024 (Q4) | -0.76-0.59 | -1 | 40.91% (+0.41) | |
| Nov 14, 2024 | 2024 (Q3) | -1.05-0.81 | -1.42 | 42.95% (+0.61) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

